首页> 美国卫生研究院文献>Frontiers in Pediatrics >Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney Disease
【2h】

Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney Disease

机译:常染色体隐性隐性多囊肾疾病的肝胆并发症的诊断和处理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Autosomal recessive polycystic kidney disease (ARPKD) is a congenital hepatorenal fibrocystic disease. The hepatic manifestations of ARPKD can range from asymptomatic to portal hypertension and massively dilated biliary system that results in liver transplantation. Hepatic complications of ARPKD typically present with signs of portal hypertension (splenomegaly and thrombocytopenia) or cholangitis. Liver disease in ARPKD does not always correlate with severity of renal disease. Management of ARPKD-related liver disease is largely treating specific symptoms, such as antibiotics for cholangitis or endoscopic treatment for variceal bleeding. If complications cannot be managed medically, liver transplantation may be indicated. This mini-review will discuss the clinical manifestations and management of children with ARPKD liver disease.
机译:常染色体隐性隐性多囊肾病(ARPKD)是一种先天性肝肾纤维囊性疾病。 ARPKD的肝表现范围从无症状到门脉高压以及导致肝脏移植的大量胆管系统扩张。 ARPKD的肝并发症通常表现为门脉高压(脾肿大和血小板减少)或胆管炎的体征。 ARPKD中的肝脏疾病并不总是与肾脏疾病的严重程度相关。与ARPKD相关的肝病的治疗主要是在治疗特定症状,例如胆管炎的抗生素或内镜治疗静脉曲张破裂的出血。如果并发症不能通过医学手段处理,则可能需要进行肝移植。这份小型综述将讨论ARPKD肝病患儿的临床表现和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号